Texas HB 3057: Relating to health benefit plan coverage for chimeric antigen receptor T-cell therapy.

Status: Effective on 9/1/25 (as of 2025-06-20)

State: Texas · Session: 89R · Bill: HB 3057

Subjects: CANCER (S0658), HEALTH & HUMAN SERVICES COMMISSION (V0177), Health--Children's Insurance (I0388), Health--Other Diseases & Medical Conditions (I0383), INSURANCE, COMMISSIONER OF (V0396), Insurance--Health & Accident (I0422), MEDICAID (S4885)

Sponsors: Landgraf, Sparks, Hinojosa, Adam

View Texas HB 3057 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.